Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2R | P25116 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1731167 | 0.84 | MAPT (0.45) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1729176 | 0.84 | MAPT (0.45) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1729276 | 0.84 | MAPT (0.41) | F2RKDM4EMAPTRAB9ANPC1 | |
| SCHEMBL6544593 | 0.84 | F2R (0.36) | F2RKDM4EMAPTRAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL1730994 | 0.83 | F2R (0.44) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1729267 | 0.83 | F2R (0.42) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL6543728 | 0.83 | F2R (0.43) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1730879 | 0.83 | RAB9A (0.38) | F2RKDM4EMAPTRAB9ANPC1 | |
| SCHEMBL14449014 | 0.83 | F2R (0.45) | F2RKDM4EMAPTRAB9ANPC1 | |
| Bromide SCHEMBL1730898 | 0.83 | F2R (0.45) | F2RKDM4EMAPTRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1391451-A1 | 2-IMINOPYRROLIDINE DERIVATES | Eisai Co., Ltd. (JP) | 2004-02-25 | — | — | EP | disclosed |